| # | Drug | Count |
|---|---|---|
| 0 | ORAL SEMAGLUTIDE | 838 |
| 1 | SILDENAFIL CITRATE | 558 |
| 2 | ASPIRIN | 193 |
| 3 | ASPIRIN 325 MG | 187 |
| 4 | ASPIRIN 81 MG | 187 |
| 5 | TIRZEPATIDE | 187 |
| 6 | METFORMIN | 145 |
| 7 | TADALAFIL | 139 |
| 8 | METFORMIN ER 500 MG | 101 |
| 9 | METFORMIN ER 750 MG | 101 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VARDENAFIL | 9 | 0.0151 |
| 1 | AVACINCAPTAD PEGOL | 5 | 0.0142 |
| 2 | ORAL SEMAGLUTIDE | 838 | 0.0107 |
| 3 | PEGCETACOPLAN | 17 | 0.0090 |
| 4 | SILDENAFIL CITRATE | 558 | 0.0044 |
| 5 | AMIODARONE HYDROCHLORIDE | 37 | 0.0033 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 20 | 0.0024 |
| 7 | BROLUCIZUMAB | 7 | 0.0019 |
| 8 | INFLIXIMAB-DYYB | 6 | 0.0017 |
| 9 | SILDENAFIL POWDER, | 59 | 0.0016 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 2 | 0.0037 |
| 1 | Interleukin-6 Antagonist [EPC] | 2 | 0.0031 |
| 2 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 3 | GLP-1 Receptor Agonist [EPC] | 1055 | 0.0024 |
| 4 | Endoglycosidase [EPC] | 4 | 0.0022 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 196 | 0.0014 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 7 | Blood Viscosity Reducer [EPC] | 6 | 0.0014 |
| 8 | Provitamin D2 Compound [EPC] | 35 | 0.0012 |
| 9 | Androgen [EPC] | 30 | 0.0011 |